These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11756949)

  • 1. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial.
    Schnopp C; Remling R; Möhrenschlager M; Weigl L; Ring J; Abeck D
    J Am Acad Dermatol; 2002 Jan; 46(1):73-7. PubMed ID: 11756949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study.
    Katsarou A; Makris M; Papagiannaki K; Lagogianni E; Tagka A; Kalogeromitros D
    Eur J Dermatol; 2012; 22(2):192-6. PubMed ID: 22407003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
    Veien NK; Olholm Larsen P; Thestrup-Pedersen K; Schou G
    Br J Dermatol; 1999 May; 140(5):882-6. PubMed ID: 10354026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus.
    Gradman J; Wolthers OD
    Acta Paediatr; 2007 Aug; 96(8):1233-7. PubMed ID: 17590198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema.
    Alomar A; Puig L; Gallardo CM; Valenzuela N
    Contact Dermatitis; 2003 Oct; 49(4):185-8. PubMed ID: 14996065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
    Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
    Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of mometasone furoate cream 0.1% applied once daily vs clobetasol propionate cream 0.05% applied twice daily in chronic eczema.
    Goh CL; Lim JT; Leow YH; Ang CB; Kohar YM
    Singapore Med J; 1999 May; 40(5):341-4. PubMed ID: 10489492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
    Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
    Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children.
    Pei AY; Chan HH; Ho KM
    Pediatr Dermatol; 2001; 18(4):343-8. PubMed ID: 11576413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema.
    Thelmo MC; Lang W; Brooke E; Osborne BE; McCarty MA; Jorizzo JL; Fleischer A
    J Dermatolog Treat; 2003 Sep; 14(3):136-40. PubMed ID: 14522622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis.
    Medansky RS; Cuffie CA; Tanner DJ
    Clin Ther; 1997; 19(4):701-9. PubMed ID: 9377614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):40-2. PubMed ID: 11952288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses.
    Kelly JW; Cains GD; Rallings M; Gilmore SJ
    Australas J Dermatol; 1991; 32(2):85-91. PubMed ID: 1781761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
    Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L
    J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
    Vernon HJ; Lane AT; Weston W
    J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
    Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; Lund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q
    Otolaryngol Head Neck Surg; 1998 May; 118(5):648-54. PubMed ID: 9591864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy.
    Lebwohl M; Peets E; Chen V
    Int J Dermatol; 1993 Nov; 32(11):830-1. PubMed ID: 8270349
    [No Abstract]   [Full Text] [Related]  

  • 20. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.